nodes	percent_of_prediction	percent_of_DWPC	metapath
Droperidol—DRD2—nicotine dependence	0.915	1	CbGaD
Droperidol—Dysphoria—Varenicline—nicotine dependence	0.00769	0.171	CcSEcCtD
Droperidol—Extrapyramidal symptoms—Varenicline—nicotine dependence	0.00641	0.142	CcSEcCtD
Droperidol—Extrapyramidal disorder—Varenicline—nicotine dependence	0.00442	0.0981	CcSEcCtD
Droperidol—DRD2—Nicotine Activity on Dopaminergic Neurons—CHRNA6—nicotine dependence	0.00386	0.114	CbGpPWpGaD
Droperidol—Blood pressure increased—Varenicline—nicotine dependence	0.00333	0.0739	CcSEcCtD
Droperidol—DRD2—Nicotine Activity on Dopaminergic Neurons—CHRNA5—nicotine dependence	0.00249	0.0735	CbGpPWpGaD
Droperidol—DRD2—Nicotine Activity on Dopaminergic Neurons—CHRNA3—nicotine dependence	0.00203	0.0599	CbGpPWpGaD
Droperidol—Pimozide—OPRM1—nicotine dependence	0.00199	0.291	CrCbGaD
Droperidol—Hyperglycaemia—Varenicline—nicotine dependence	0.00188	0.0418	CcSEcCtD
Droperidol—Depression—Varenicline—nicotine dependence	0.00185	0.0412	CcSEcCtD
Droperidol—DRD2—Nicotine Activity on Dopaminergic Neurons—CHRNB2—nicotine dependence	0.00178	0.0528	CbGpPWpGaD
Droperidol—Hallucination—Varenicline—nicotine dependence	0.00166	0.0369	CcSEcCtD
Droperidol—DRD2—Nicotine Activity on Dopaminergic Neurons—CHRNA4—nicotine dependence	0.00162	0.0479	CbGpPWpGaD
Droperidol—Chills—Varenicline—nicotine dependence	0.0015	0.0333	CcSEcCtD
Droperidol—Fluspirilene—DRD2—nicotine dependence	0.00146	0.213	CrCbGaD
Droperidol—Angioedema—Varenicline—nicotine dependence	0.00133	0.0295	CcSEcCtD
Droperidol—Domperidone—DRD2—nicotine dependence	0.00131	0.191	CrCbGaD
Droperidol—Syncope—Varenicline—nicotine dependence	0.0013	0.029	CcSEcCtD
Droperidol—Palpitations—Varenicline—nicotine dependence	0.00128	0.0285	CcSEcCtD
Droperidol—Loss of consciousness—Varenicline—nicotine dependence	0.00128	0.0284	CcSEcCtD
Droperidol—Hypertension—Varenicline—nicotine dependence	0.00126	0.0279	CcSEcCtD
Droperidol—Anxiety—Varenicline—nicotine dependence	0.00123	0.0274	CcSEcCtD
Droperidol—ADRA1A—G alpha (12/13) signalling events—FGD1—nicotine dependence	0.00118	0.0349	CbGpPWpGaD
Droperidol—Shock—Varenicline—nicotine dependence	0.00117	0.0259	CcSEcCtD
Droperidol—Tachycardia—Varenicline—nicotine dependence	0.00116	0.0257	CcSEcCtD
Droperidol—Hypotension—Varenicline—nicotine dependence	0.00111	0.0246	CcSEcCtD
Droperidol—Pimozide—DRD2—nicotine dependence	0.00109	0.159	CrCbGaD
Droperidol—Somnolence—Varenicline—nicotine dependence	0.00105	0.0234	CcSEcCtD
Droperidol—Haloperidol—DRD2—nicotine dependence	0.000998	0.146	CrCbGaD
Droperidol—KCNH2—SIDS Susceptibility Pathways—CHRNB4—nicotine dependence	0.000976	0.0289	CbGpPWpGaD
Droperidol—Body temperature increased—Varenicline—nicotine dependence	0.000938	0.0208	CcSEcCtD
Droperidol—KCNH2—Neuronal System—CHRNB3—nicotine dependence	0.000933	0.0276	CbGpPWpGaD
Droperidol—HTR2A—Monoamine GPCRs—DRD2—nicotine dependence	0.000904	0.0267	CbGpPWpGaD
Droperidol—ADRA1A—Monoamine GPCRs—DRD2—nicotine dependence	0.000885	0.0262	CbGpPWpGaD
Droperidol—KCNH2—Neuronal System—CHRNA6—nicotine dependence	0.000884	0.0262	CbGpPWpGaD
Droperidol—Hypersensitivity—Varenicline—nicotine dependence	0.000874	0.0194	CcSEcCtD
Droperidol—Dizziness—Varenicline—nicotine dependence	0.000785	0.0174	CcSEcCtD
Droperidol—HTR2A—Amine ligand-binding receptors—DRD2—nicotine dependence	0.00076	0.0225	CbGpPWpGaD
Droperidol—Rash—Varenicline—nicotine dependence	0.000748	0.0166	CcSEcCtD
Droperidol—Dermatitis—Varenicline—nicotine dependence	0.000747	0.0166	CcSEcCtD
Droperidol—ADRA1A—Amine ligand-binding receptors—DRD2—nicotine dependence	0.000744	0.022	CbGpPWpGaD
Droperidol—KCNH2—SIDS Susceptibility Pathways—CHRNB2—nicotine dependence	0.000651	0.0193	CbGpPWpGaD
Droperidol—KCNH2—Neuronal System—GABRA4—nicotine dependence	0.000639	0.0189	CbGpPWpGaD
Droperidol—DRD2—G alpha (i) signalling events—TAS2R16—nicotine dependence	0.000627	0.0185	CbGpPWpGaD
Droperidol—KCNH2—Neuronal System—CHRNB4—nicotine dependence	0.000613	0.0181	CbGpPWpGaD
Droperidol—KCNH2—SIDS Susceptibility Pathways—CHRNA4—nicotine dependence	0.000591	0.0175	CbGpPWpGaD
Droperidol—KCNH2—Neuronal System—CHRNA5—nicotine dependence	0.00057	0.0169	CbGpPWpGaD
Droperidol—HTR2A—SIDS Susceptibility Pathways—CHRNB4—nicotine dependence	0.000529	0.0156	CbGpPWpGaD
Droperidol—KCNH2—Neuronal System—CHRNA3—nicotine dependence	0.000464	0.0137	CbGpPWpGaD
Droperidol—KCNH2—Neuronal System—CHRNB2—nicotine dependence	0.000409	0.0121	CbGpPWpGaD
Droperidol—DRD2—GPCR ligand binding—TAS2R16—nicotine dependence	0.000379	0.0112	CbGpPWpGaD
Droperidol—HTR2A—GPCR ligand binding—TAS2R16—nicotine dependence	0.000373	0.011	CbGpPWpGaD
Droperidol—KCNH2—Neuronal System—CHRNA4—nicotine dependence	0.000371	0.011	CbGpPWpGaD
Droperidol—ADRA1A—GPCR ligand binding—TAS2R16—nicotine dependence	0.000366	0.0108	CbGpPWpGaD
Droperidol—HTR2A—SIDS Susceptibility Pathways—CHRNB2—nicotine dependence	0.000353	0.0104	CbGpPWpGaD
Droperidol—HTR2A—SIDS Susceptibility Pathways—CHRNA4—nicotine dependence	0.00032	0.00948	CbGpPWpGaD
Droperidol—DRD2—Circadian rythm related genes—CHRNB2—nicotine dependence	0.000293	0.00866	CbGpPWpGaD
Droperidol—DRD2—G alpha (i) signalling events—OPRM1—nicotine dependence	0.000264	0.00782	CbGpPWpGaD
Droperidol—DRD2—GPCRs, Class A Rhodopsin-like—OPRM1—nicotine dependence	0.000245	0.00725	CbGpPWpGaD
Droperidol—HTR2A—GPCRs, Class A Rhodopsin-like—OPRM1—nicotine dependence	0.000241	0.00714	CbGpPWpGaD
Droperidol—ADRA1A—GPCRs, Class A Rhodopsin-like—OPRM1—nicotine dependence	0.000236	0.00699	CbGpPWpGaD
Droperidol—DRD2—GPCR downstream signaling—TAS2R16—nicotine dependence	0.000214	0.00634	CbGpPWpGaD
Droperidol—HTR2A—GPCR downstream signaling—TAS2R16—nicotine dependence	0.000211	0.00624	CbGpPWpGaD
Droperidol—DRD2—Class A/1 (Rhodopsin-like receptors)—OPRM1—nicotine dependence	0.00021	0.00621	CbGpPWpGaD
Droperidol—HTR2A—Class A/1 (Rhodopsin-like receptors)—OPRM1—nicotine dependence	0.000207	0.00611	CbGpPWpGaD
Droperidol—ADRA1A—GPCR downstream signaling—TAS2R16—nicotine dependence	0.000207	0.00611	CbGpPWpGaD
Droperidol—ADRA1A—Class A/1 (Rhodopsin-like receptors)—OPRM1—nicotine dependence	0.000202	0.00599	CbGpPWpGaD
Droperidol—DRD2—Signaling by GPCR—TAS2R16—nicotine dependence	0.000195	0.00576	CbGpPWpGaD
Droperidol—HTR2A—Signaling by GPCR—TAS2R16—nicotine dependence	0.000192	0.00567	CbGpPWpGaD
Droperidol—ADRA1A—Signaling by GPCR—TAS2R16—nicotine dependence	0.000188	0.00555	CbGpPWpGaD
Droperidol—HTR2A—GPCRs, Class A Rhodopsin-like—DRD2—nicotine dependence	0.000174	0.00516	CbGpPWpGaD
Droperidol—ADRA1A—GPCRs, Class A Rhodopsin-like—DRD2—nicotine dependence	0.000171	0.00505	CbGpPWpGaD
Droperidol—DRD2—GPCR downstream signaling—FGD1—nicotine dependence	0.000168	0.00498	CbGpPWpGaD
Droperidol—HTR2A—GPCR downstream signaling—FGD1—nicotine dependence	0.000166	0.0049	CbGpPWpGaD
Droperidol—ADRA1A—GPCR downstream signaling—FGD1—nicotine dependence	0.000162	0.0048	CbGpPWpGaD
Droperidol—DRD2—GPCR ligand binding—OPRM1—nicotine dependence	0.00016	0.00473	CbGpPWpGaD
Droperidol—HTR2A—GPCR ligand binding—OPRM1—nicotine dependence	0.000157	0.00466	CbGpPWpGaD
Droperidol—ADRA1A—GPCR ligand binding—OPRM1—nicotine dependence	0.000154	0.00456	CbGpPWpGaD
Droperidol—DRD2—Signaling by GPCR—FGD1—nicotine dependence	0.000153	0.00452	CbGpPWpGaD
Droperidol—HTR2A—Signaling by GPCR—FGD1—nicotine dependence	0.00015	0.00445	CbGpPWpGaD
Droperidol—HTR2A—Class A/1 (Rhodopsin-like receptors)—DRD2—nicotine dependence	0.000149	0.00442	CbGpPWpGaD
Droperidol—ADRA1A—Signaling by GPCR—FGD1—nicotine dependence	0.000147	0.00435	CbGpPWpGaD
Droperidol—ADRA1A—Class A/1 (Rhodopsin-like receptors)—DRD2—nicotine dependence	0.000146	0.00433	CbGpPWpGaD
Droperidol—DRD2—Signaling Pathways—TAS2R16—nicotine dependence	0.000115	0.0034	CbGpPWpGaD
Droperidol—HTR2A—GPCR ligand binding—DRD2—nicotine dependence	0.000114	0.00337	CbGpPWpGaD
Droperidol—HTR2A—Signaling Pathways—TAS2R16—nicotine dependence	0.000113	0.00335	CbGpPWpGaD
Droperidol—ADRA1A—GPCR ligand binding—DRD2—nicotine dependence	0.000111	0.0033	CbGpPWpGaD
Droperidol—ADRA1A—Signaling Pathways—TAS2R16—nicotine dependence	0.000111	0.00328	CbGpPWpGaD
Droperidol—DRD2—GPCR downstream signaling—OPRM1—nicotine dependence	9.04e-05	0.00267	CbGpPWpGaD
Droperidol—DRD2—Signaling Pathways—FGD1—nicotine dependence	9.03e-05	0.00267	CbGpPWpGaD
Droperidol—HTR2A—GPCR downstream signaling—OPRM1—nicotine dependence	8.9e-05	0.00263	CbGpPWpGaD
Droperidol—HTR2A—Signaling Pathways—FGD1—nicotine dependence	8.88e-05	0.00263	CbGpPWpGaD
Droperidol—ADRA1A—GPCR downstream signaling—OPRM1—nicotine dependence	8.71e-05	0.00258	CbGpPWpGaD
Droperidol—ADRA1A—Signaling Pathways—FGD1—nicotine dependence	8.7e-05	0.00257	CbGpPWpGaD
Droperidol—DRD2—Signaling by GPCR—OPRM1—nicotine dependence	8.21e-05	0.00243	CbGpPWpGaD
Droperidol—HTR2A—Signaling by GPCR—OPRM1—nicotine dependence	8.08e-05	0.00239	CbGpPWpGaD
Droperidol—DRD2—Signaling Pathways—AKR1B10—nicotine dependence	7.97e-05	0.00236	CbGpPWpGaD
Droperidol—ADRA1A—Signaling by GPCR—OPRM1—nicotine dependence	7.91e-05	0.00234	CbGpPWpGaD
Droperidol—HTR2A—Signaling Pathways—AKR1B10—nicotine dependence	7.85e-05	0.00232	CbGpPWpGaD
Droperidol—ADRA1A—Signaling Pathways—AKR1B10—nicotine dependence	7.68e-05	0.00227	CbGpPWpGaD
Droperidol—HTR2A—GPCR downstream signaling—DRD2—nicotine dependence	6.43e-05	0.0019	CbGpPWpGaD
Droperidol—ADRA1A—GPCR downstream signaling—DRD2—nicotine dependence	6.3e-05	0.00186	CbGpPWpGaD
Droperidol—HTR2A—Signaling by GPCR—DRD2—nicotine dependence	5.84e-05	0.00173	CbGpPWpGaD
Droperidol—ADRA1A—Signaling by GPCR—DRD2—nicotine dependence	5.72e-05	0.00169	CbGpPWpGaD
Droperidol—DRD2—Signaling Pathways—WASF2—nicotine dependence	5.62e-05	0.00166	CbGpPWpGaD
Droperidol—HTR2A—Signaling Pathways—WASF2—nicotine dependence	5.53e-05	0.00164	CbGpPWpGaD
Droperidol—ADRA1A—Signaling Pathways—WASF2—nicotine dependence	5.41e-05	0.0016	CbGpPWpGaD
Droperidol—DRD2—Signaling Pathways—WASF1—nicotine dependence	5.39e-05	0.00159	CbGpPWpGaD
Droperidol—HTR2A—Signaling Pathways—WASF1—nicotine dependence	5.3e-05	0.00157	CbGpPWpGaD
Droperidol—ADRA1A—Signaling Pathways—WASF1—nicotine dependence	5.19e-05	0.00153	CbGpPWpGaD
Droperidol—DRD2—Signaling Pathways—OPRM1—nicotine dependence	4.85e-05	0.00143	CbGpPWpGaD
Droperidol—HTR2A—Signaling Pathways—OPRM1—nicotine dependence	4.77e-05	0.00141	CbGpPWpGaD
Droperidol—ADRA1A—Signaling Pathways—OPRM1—nicotine dependence	4.67e-05	0.00138	CbGpPWpGaD
Droperidol—HTR2A—Signaling Pathways—DRD2—nicotine dependence	3.45e-05	0.00102	CbGpPWpGaD
Droperidol—ADRA1A—Signaling Pathways—DRD2—nicotine dependence	3.38e-05	0.000999	CbGpPWpGaD
